Very interesting. It seems the science is clear. The key to lowering new HIV infections among all people, including African Americans, will require taking full advantage of the advances that research has provided and making the most efficient and effective use of the tools now available. Treatment as prevention and pre-exposure prophylaxis are the most powerful tools in our HIV toolkit. Yet, too many people are not aware of these new tools and the latest data on their effectiveness, so work needs to be done to educate many more people about the latest science.
“Among those on antiretroviral therapy (ART), women and racial/ethnic minorities are more likely to discontinue ART and racial/ethnic minorities experience virologic failure at higher rates”(McFall et al., 2013). With the correlation of virologic failure in African American women the research to determine the underlying cause of the ART being discontinued will be of great importance to provide the support this group of women need.
Are there any current approaches of support available for these women?
Reference
McFall, A., Dowdy, D., Zelaya, C., Murphy, K., Wilson, T. E., Young M. A., Gandhi, M. Cohen, M. H., Golub, E. T., Althoff, K. N. (2013). Understanding the disparity: Predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity. JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(3):289–298. DOI: 10.1097/QAI.0b013e3182a095e9
I am sorry but I am not able to open your file.
Very interesting. It seems the science is clear. The key to lowering new HIV infections among all people, including African Americans, will require taking full advantage of the advances that research has provided and making the most efficient and effective use of the tools now available. Treatment as prevention and pre-exposure prophylaxis are the most powerful tools in our HIV toolkit. Yet, too many people are not aware of these new tools and the latest data on their effectiveness, so work needs to be done to educate many more people about the latest science.
Wolitski, R. (2018, February 7). HIV in the African American Community: Progress, But Our Work Is Far From Over. Retrieved from HIV.gov: https://www.hiv.gov/blog/hiv-african-american-community-progress-our-work-far-over
Thankfully I am now able to open your poster.
“Among those on antiretroviral therapy (ART), women and racial/ethnic minorities are more likely to discontinue ART and racial/ethnic minorities experience virologic failure at higher rates”(McFall et al., 2013). With the correlation of virologic failure in African American women the research to determine the underlying cause of the ART being discontinued will be of great importance to provide the support this group of women need.
Are there any current approaches of support available for these women?
Reference
McFall, A., Dowdy, D., Zelaya, C., Murphy, K., Wilson, T. E., Young M. A., Gandhi, M. Cohen, M. H., Golub, E. T., Althoff, K. N. (2013). Understanding the disparity: Predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity. JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(3):289–298. DOI: 10.1097/QAI.0b013e3182a095e9